Physician profile
Tyler Daniel Sten
NPI 1861020737
$22,655.14
in general payments reported to CMS, 2019-2025
26 companies · $4,810 in 2025
The $4,810 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.96 · 2022: $2,646 · 2023: $10K · 2024: $5,037 · 2025: $4,810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,779 · Travel and Lodging: $7,632 · Consulting Fee: $2,500 · Gift: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,778.58 |
| Travel and Lodging | $7,632.37 |
| Consulting Fee | $2,500.00 |
| Gift | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $9,761.66 | 2022-2025 | Inbone, Hoffmann, Variax |
| Integra Lifesciences Corporation | $3,298.89 | 2023-2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Crossroads Orthopedics, LLC | $2,487.55 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $1,708.59 | 2023 | Trabecular Metal |
| Medline Industries LP | $936.40 | 2023 | |
| Mimedx Group, INC. | $817.60 | 2024-2025 | |
| International Life Sciences | $660.56 | 2023 | |
| Organogenesis INC. | $552.91 | 2024-2025 | Puraply Wound Matrix, Nushield, Affinity |
| Kerecis Limited | $397.09 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Paragon 28, INC. | $370.15 | 2023 | Apex 3d |
| Treace Medical Concepts, INC. | $330.88 | 2025 | |
| Orthofix Medical, INC. | $282.08 | 2023-2025 | Physio-Stim, Truelok |
| Convatec INC. | $178.87 | 2023-2025 | |
| Medtronic, INC. | $124.19 | 2022 | |
| Depuy Synthes Sales INC. | $107.47 | 2023-2025 | Motoband, Motoband Cp |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trice Medical, INC. | $102.49 | 2025 | |
| Acumed LLC | $89.89 | 2024-2025 | Acumed, Osteomed, Innate Implant |
| Heron Therapeutics, INC. | $87.96 | 2021 | |
| Smith+Nephew, INC. | $83.14 | 2023-2024 | Collagenase Santyl, Pico 7, Stravix |
| Linvatec Corporation | $69.68 | 2024 | Biobrace 23mm |
| Titan Surgical Group, LLC | $43.01 | 2024 | |
| Polynovo North America LLC | $38.71 | 2024-2025 | Novosorb Btm |
| Biocomposites INC | $37.57 | 2024-2025 | Stimulan |
| Averitas Pharma INC. | $36.54 | 2023 | Qutenza |
| Paratek Pharmaceuticals, INC. | $31.73 | 2024-2025 | Nuzyra |
| Solventum Corporation | $19.53 | 2025 | Prevena, V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Sten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.